You are here

belrestotug

GSK axes $625M TIGIT drug as midphase data disappoint, promoting partner iTeos to cut costs

Fierce Biotech

Tue, 05/13/25 - 11:27 am

iTeos Therapeutics

TIGIT drug from iTeos shrinks lung tumors in trial

BioPharma Dive

Sun, 09/15/24 - 06:28 pm

iTeos Therapeutics

Iteos – and GSK – keep the faith

EP Vantage

Tue, 05/9/23 - 10:40 am

iTeos Therapeutics